Publicerad 16 april 2024 I år arrangerades CASE-dagen på Campus Helsingborg. Foto: Lill Eriksson Runt 160 personer gästade CASE-dagen den 16 april, som i år arrangerades på Campus Helsingborg. Tema för dagen var goda levnadsvillkor för den åldrande befolkningen. Vad hoppas ni få ut av dagen?– Mer kunskap, då kan vi i PRO driva på. Vi är ju många äldre och vi ska tuffa till oss. Sådan här forskning

https://www.ch.lu.se/artikel/en-dag-goda-levnadsvillkor - 2025-05-07

Publicerad 19 april 2024 "Resultaten från studien visar att det både är tidskrävande och ekonomiskt utmanande att vara en cirkulär modekonsument" säger forskaren Emma Samsioe. Klädindustrin är ett hållbarhetsproblem och samtidigt som cirkulär ekonomi kan vara lösningen är det svårt att skapa en omställning som passar konsumenten. I ett nyligen avslutat forskningsprojekt undersöktes det hur konsume

https://www.ch.lu.se/artikel/hinder-och-mojligheter-cirkular-modekonsumtion - 2025-05-07

Publicerad 18 april 2024 Illustration: Arkitekterna Krook & Tjäder 2050 har hela södra delen av Helsingborg förändrats och utvecklats. När hamnen flyttar öppnas möjligheter till att skapa något nytt och unikt i stadsplanen. Men hur ska alla trivas och hur ska alla olika verksamheter fungera tillsammans? Vad händer med platsens identitet och den anknytning som helsingborgarna har till platsen? Hur

https://www.ch.lu.se/artikel/podd-vem-bestammer-hur-staden-utvecklas - 2025-05-07

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 22 June 2020 A new joint report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) presents the largest venture ever on precision medicine in diabetes. The report includes a detailed overview and roadmap for how this new approach to diabetes medicine can be evaluate

https://www.ludc.lu.se/article/roadmap-precision-medicine-diabetes-care - 2025-05-07

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 23 June 2020 The research group Nutritional Epidemiology has started a blog, www.nutrition.blogg.lu.se! Esther González-Padilla tells us more about it. Visit nutrition.blogg.lu.se, a blog about nutritional science. ​​​​​What is the blog about?We have started the blog mostly as a tool to inform people, within and outside

https://www.ludc.lu.se/article/new-blog-about-nutriton - 2025-05-07

Published 24 June 2020 Karin Stenkula, Emily Sonestedt and Sebastian Kalamajski have received grants from the The Bo and Kerstin Hjelt Diabetes Foundation. Read about their research projects here. Karin Stenkula, Lund University Diabetes Centre:EHD2: a novel candidate essential for lipid transport and overall glucose homeostasisObesity is one of the main risk factors behind type 2 diabetes and car

https://www.ludc.lu.se/article/hjelt-foundations-grant-holders-2020 - 2025-05-07

Published 13 August 2020 A new COVID-19 antibody test developed by scientists at Lund University in Sweden has shown robust performance upon clinical validation and application. The test detects antibodies in the blood targeting the spike protein of SARS-CoV-2, and determines in just 15 minutes whether a person has had COVID-19, regardless of whether they have had any symptoms. “Unlike other serol

https://www.ludc.lu.se/article/new-rapid-and-robust-covid-19-antibody-test-developed - 2025-05-07

Published 29 August 2020 Last week it was announced that our longtime colleague and LUDC researcher/SUS clinician Martin Ridderstråle has been appointed Senior Vice President of Patient Care in the Novo Nordisk Foundation. This is not only a remarkable achievement by Martin but also goes to show that our environment fosters excellent scientists and outstanding clinicians. Martin is one of the most

https://www.ludc.lu.se/article/senior-vice-president-patient-care-novo-nordisk-foundation - 2025-05-07

Published 25 September 2020 Karl Bacos, assistant researcher at LUDC is the recipient of 2020 years Medeon stipend of 50 000 sek for his innovative work within epigenetics in diabetes.   Medeonstipendiat 2020, Karl Bacos, PhD, docent, Lund University Diabetes Centre, Picture: Sara Liedholm The Medeon stipend is handed out in connection to the acknowledgement of World Diabetes Day in Skåne which ta

https://www.ludc.lu.se/article/karl-bacos-years-recipient-medeon-stipend - 2025-05-07

Published 13 August 2020 In many studies, bariatric surgery has been highlighted as an almost magical method for weight loss and reversing type 2 diabetes. One question that has remained largely unanswered is how the effect of surgery differs from the effects of a strict low-calorie diet. This question has now been examined by researchers at Lund University in Sweden in a study published in the jo

https://www.ludc.lu.se/article/strict-diet-explains-metabolic-effect-gastric-pass-surgery - 2025-05-07

Published 30 September 2020 Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating. Researchers at Lund University in Sweden have now identified biomarkers that can show in advance how the patient wil

https://www.ludc.lu.se/article/metformin-type-2-diabetes-patients-or-not-researchers-now-have-answer - 2025-05-07

Published 9 October 2020 Should patients with separate variants of type 2 diabetes be treated with different types of drugs? Researchers at Lund University in Sweden and Skåne University Hospital will attempt to answer that question in a new study.   Anders Rosengren (Image: Johan Wingborg) Type 2 diabetes is one of the fastest growing diseases in the world. It is estimated that over 300 million p

https://www.ludc.lu.se/article/new-study-personalized-type-2-diabetes-treatment-launched - 2025-05-07

Published 21 December 2020 Our latest study on COVID-19 transmission risk among healthcare professionals, a collaboration between Prof Magnus Rasmussen (Dep. of Infection Medicine) and Associate Professor Yang De Marinis (Dep. of Clinical Sciences).  The study was conducted on ~500 healthcare professionals and staff members from 9 units at the Skåne University Hospital in Malmö and Lund, as well a

https://www.ludc.lu.se/article/study-covid-19-among-healthcare-professionals - 2025-05-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 5 July 2021 Researchers at Lund University Diabetes Centre are studying whether different subgroups of diabetes need different treatment. Newborn babies are already being screened for mutations and genetic tests help families with hereditary breast cancer. Genomic-driven precision medicine (GDPM) is an emerging approach fo

https://www.ludc.lu.se/article/precision-medicine-emerging-approach-complex-diseases - 2025-05-07

By bodil [dot] malmstrom [at] med [dot] lu [dot] se (Bodil Malmström) - published 9 June 2021 Data from participants in Sweden has helped researchers understand the complexity of the corona virus. Photo: Istock During the pandemic, the free COVID Symptom Study app has helped researchers understand the complexity and spread of the corona virus better. “The study has exceeded our expectations since

https://www.ludc.lu.se/article/study-tracks-spread-covid-19-sweden - 2025-05-07

Published 18 June 2021 The grants from the Crafoord Foundation will support a wide range of projects in diabetes research. Photo: Kennet Ruona Researchers from Lund University Diabetes Centre (LUDC) receive 5,3 million SEK in grants from the Crafoord Foundation in southern Sweden. This year, 15 researchers from LUDC are awarded grants for a wide range of projects in diabetes research. In total, re

https://www.ludc.lu.se/article/15-researchers-lund-university-diabetes-centre-receive-millions-funding - 2025-05-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 12 November 2021 Yang De Marinis has led the study, which is published in Nature Communications. Photo: Johan Bävman Type 2 diabetes is a complex disease that can lead to serious health problems. It is important to find ways to predict the disease to take preventive measures. A large interdisciplinary study led by Lund Uni

https://www.ludc.lu.se/article/blood-biomarker-identified-predicts-type-2-diabetes-several-years-diagnosis - 2025-05-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 31 August 2021 Current screening methods require multiple blood samples. New research shows that a fingerstick blood test can be sufficient. Photo: Petra Olsson Diabetes researchers have established methods for screening people with an increased risk of developing type 1 diabetes. Current methods require multiple blood sam

https://www.ludc.lu.se/article/improved-screening-efficiency-type-1-diabetes-simplified-blood-draw - 2025-05-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 12 October 2021 Karl Bacos, a researcher in diabetes and epigenetics, receives a generous grant from the Hjelt Diabetes Foundation. Photo: Petra Olsson Three researchers at Lund University Diabetes Centre (LUDC) receive generous grants from the Hjelt Diabetes Foundation in 2021. Ola Hansson, Karl Bacos and Malin Fex have b

https://www.ludc.lu.se/article/hjelt-foundation-grants-mechanistic-studies-type-2-diabetes - 2025-05-07

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 11 November 2021 Charlotte Ling leads a research group in epigenetics and diabetes at Lund University. Emma Nilsson and Jones Ofori are two of the team members. Photo: Kennet Ruona Metformin is often described as the first-line medication for the treatment of type 2 diabetes. However, not all patients respond to the drug.

https://www.ludc.lu.se/article/diabetes-research-collaboration-can-pave-way-innovation - 2025-05-07